Drugs / Lyophilized Microbiota
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT02449174 Comparator | Mar 2015 → Dec 2017 | Clostridium difficile colitis | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lyophilized Microbiota | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02449174 ↗ |
| Modality | Other / unclassified | “lyophilized donor intestinal bacteria” NCT02449174 ↗ |
| Route | Oral | “Lyophilized Microbiota will be delivered orally.” NCT02449174 ↗ |